Drug Profile
MER W8020
Latest Information Update: 02 Sep 1998
Price :
$50
*
At a glance
- Originator Mercian
- Class Analgesics; Anti-inflammatories; Antirheumatics; Depsipeptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain; Rheumatoid arthritis
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Pain in Japan (Intraperitoneal)
- 02 Sep 1998 No-Development-Reported for Rheumatoid arthritis in Japan (Intraperitoneal)
- 13 Sep 1996 Preclinical development for Pain in Japan (Intraperitoneal)